Showing results (61-70 of 330) with videos related to
Sort By:
Pageof 33
Psychopharmacology|January 1, 1995
Oral tardive dyskinesia: validation of a measuring device using digital image processingC Büchel, J de Leon, G M Simpson, et al.Biological Psychiatry|January 1, 1995
Decreased phospholipase A2 activity in Alzheimer brainsW F Gattaz, A Maras, N J Cairns, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|February 1, 2005
Modulation of phospholipase A2 activity in primary cultures of rat cortical neuronsC T Mendes, W F Gattaz, E L Schaeffer, et al.Fortschritte Der Neurologie, Psychiatrie, Und Ihrer Grenzgebiete|October 1, 1978
[Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)]H BeckmannEuropean Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Developmental malformations in cerebral structures of schizophrenic patientsH BeckmannPharmacopsychiatry|June 29, 2011
Increased brain membrane fluidity in schizophreniaG P Eckert, E L Schaeffer, A Schmitt, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
Digital movement analysis, a new objective method of measuring tardive dyskinesia and drug-induced parkinsonian tremor: acceptability, reliability and validityF M Nilsson, B L Hansen, C Buchel, et al.Psychiatry Research|December 1, 1988
CT scans and neuroleptic response in schizophrenia: a multidimensional approachW F Gattaz, W Rost, K Kohlmeyer, et al.Biological Psychiatry|April 1, 1987
Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapyW F Gattaz, M Köllisch, T Thuren, et al.Pageof 33